ALT-100 (Human IgG1)
ALT-100 (Human IgG1) is a humanized IgG1 monoclonal antibody that targets NAMPT. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control[2].
Product Specifications
UNSPSC
12352203
Target
NAMPT
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.90
Smiles
[ALT-100(HumanIgG1)]
Molecular Weight
(144.9 kDa)
References & Citations
[1]Liu Z, et al. An eNAMPT-neutralizing mAb reduces post-infarct myocardial fibrosis and left ventricular dysfunction. Biomed Pharmacother. 2024 Jan;170:116103.|[2]Joe G.N, et al. Anti-nampt antibodies and uses thereof. WO2021026508A1. 2021-02-11.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1098104 1.0 µg DNA
IRF1 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
bs-6089R-BF594 100 µL
RASSF8 Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details 
